Today: 17 July 2026
Disney stock set for Monday spotlight after FCC probes ABC’s “The View”
8 February 2026
2 mins read

Disney stock set for Monday spotlight after FCC probes ABC’s “The View”

New York, Feb 8, 2026, 5:05 p.m. EST — The session wrapped up with markets shut for the day.

  • Disney stock ended Friday higher, gaining 3.6% to close at $108.70.
  • The FCC has launched a probe involving ABC’s “The View” over compliance with election “equal time” regulations.
  • Investors are waiting to see if Disney makes a move before markets open again Monday.

Walt Disney Co shares could see action when U.S. markets open Monday, following word that regulators have launched an investigation connected to ABC’s daytime talk show “The View.” The stock finished Friday at $108.70, up 3.55%. Yahoo Finance

Timing is key here. Disney only recently stabilized following a volatile reaction to earnings, so any new regulatory risk tied to ABC could swiftly weigh on sentiment—even if the immediate numbers stay put.

Disney caught a lift from Friday’s sweeping rally, sending the Dow past the 50,000 mark for a record finish and boosting the S&P 500 roughly 2%. When the whole market’s surging, it can mask individual company concerns for a day or so, though those issues usually re-emerge before long.

The Federal Communications Commission is reviewing whether an appearance by Texas state Rep. James Talarico—who’s running as a Democrat for the Senate—triggers the “equal time” rule for other candidates. That rule requires broadcast stations to give any legally qualified candidate the same shot, though the FCC has recently clarified that neither daytime nor late-night talk shows get a free pass under the traditional “bona fide news” carve-out. FCC Commissioner Anna Gomez rejected the inquiry, calling it “government intimidation, not a legitimate investigation.” Disney and ABC News wouldn’t say anything in response. Reuters

Investors are still sorting through the latest earnings story. On Feb. 2, Disney flagged “headwinds” hitting international attendance at its U.S. parks and reported that operating profit in its entertainment division dropped 35% on the back of steep marketing spend—even as revenue climbed 5% to $26 billion and adjusted earnings cleared expectations. The company stuck with its outlook for double-digit per-share earnings growth and maintained plans to buy back $7 billion in shares. “The share price drop is very much to do with the parks business,” said Ben Barringer, head of technology research at Quilter Cheviot. Reuters

The FCC flap might not last long from a trading perspective. Investigations like this can stretch on, and actual enforcement of equal-time rules rarely happens. Still, it keeps political questions circling a company already watched for its news and entertainment holdings.

Investors aren’t ignoring the risks, either. Should the regulator toughen or broaden its approach, broadcasters may have to overhaul how they schedule candidates on talk shows—a potential headache, especially during campaign season.

The immediate question for Monday is straightforward: will Disney release any statements before the market opens? Investors, preoccupied lately with parks demand and streaming growth, may come up with new questions for management if the issue draws attention.

Looking past the upcoming session, Disney does have another date on the books. According to the company’s proxy statement, the 2026 annual meeting is set for Wednesday, March 18, at 10:00 a.m. Pacific, and will take place online.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • CareDx (CDNA) Shares Soar 35.6% on Medicare Coverage Approval; Outlook Still Mixed
    July 17, 2026, 7:00 AM EDT. Shares of CareDx (CDNA) climbed 35.6% to finish at $40.34 after the company secured Medicare Local Coverage Determination (LCD) for its transplant molecular tests. The new policy secures reimbursement for products monitoring kidney, heart, and lung transplants. CareDx forecasts quarterly earnings of $0.22 per share-representing a 120% increase from the previous year-and revenue of $114.35 million, up 31.9%. However, recent stability in earnings per share forecasts points to potential caution. CareDx is rated Zacks Rank #3 (Hold). In the same industry, HCA Healthcare (HCA) advanced 1.8%, but its earnings estimates edged lower, earning a Zacks Rank #4 (Sell). Investors are advised to watch upcoming earnings estimate changes for more signals regarding CDNA's momentum.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff
Previous Story

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

Dauch (DCH) stock rises in early trade as board changes and exec share award hit filings
Next Story

Dauch (DCH) stock rises in early trade as board changes and exec share award hit filings

Go toTop